Special Issue “Effects of Dyslipidemia and Metabolic Syndrome on Cardiac and Vascular Dysfunction” DOI Open Access
Isotta Chimenti, Vittoria Cammisotto

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 26(1), P. 155 - 155

Published: Dec. 27, 2024

The global increase in dysmetabolic conditions such as hyperglycemia, insulin resistance, dyslipidemia, metabolic syndrome, and type 2 diabetes is becoming a significant healthcare concern [...]

Language: Английский

Relationship between lipoprotein B and the severity of coronary microvascular dysfunction DOI Creative Commons
Lili Yang, Jingjing Zhang,

Jingnan Han

et al.

Clinical and Experimental Hypertension, Journal Year: 2025, Volume and Issue: 47(1)

Published: March 18, 2025

Objective Contributing factors for the development of heart failure (HF) involve both apolipoprotein B (ApoB) and coronary microvascular dysfunction (CMD). Although ApoB has been linked to diverse cardiovascular risks, its association with CMD remains unclear.

Language: Английский

Citations

0

Special Issue “Effects of Dyslipidemia and Metabolic Syndrome on Cardiac and Vascular Dysfunction” DOI Open Access
Isotta Chimenti, Vittoria Cammisotto

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 26(1), P. 155 - 155

Published: Dec. 27, 2024

The global increase in dysmetabolic conditions such as hyperglycemia, insulin resistance, dyslipidemia, metabolic syndrome, and type 2 diabetes is becoming a significant healthcare concern [...]

Language: Английский

Citations

0